Keyphrases
Titration
100%
Guideline-directed Medical Therapy
100%
Heart Failure Medication
100%
Dapagliflozin
41%
Sacubitril-valsartan
33%
Angiotensin Receptor Blockers
25%
Target Dose
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
United States
16%
Japan
16%
Beta-blockers
16%
Sweden
16%
Heart Failure Hospitalization
16%
Mineralocorticoid Receptor Antagonists
16%
Heart Failure Patients
8%
Clinical Practice
8%
Patients with Heart Failure
8%
Routine Care
8%
Rehospitalization
8%
Therapy Initiation
8%
Observational Cohort Study
8%
Reduced Ejection Fraction
8%
Early Initiation
8%
Recommended Dose
8%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
8%
Up-titration
8%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Heart Failure
100%
Combination Therapy
100%
Dapagliflozin
41%
Valsartan/Sacubitril
33%
Angiotensin Receptor Antagonist
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Beta Adrenergic Receptor Blocking Agent
16%
Mineralocorticoid Antagonist
16%
Cohort Study
8%
Sodium Glucose Cotransporter 2 Inhibitor
8%